C92.2 - Atypical chronic myeloid leukemia, BCR/ABL-negative
- Applicable to Atypical chronic myeloid leukemia, BCR/ABL-negative
- The 2025 edition of ICD10-CM C92.2 became effective on October 1, 2024.
- This is the American ICD10-CM version of C92.2 - other international versions of ICD10 C92.2 may differ.
- C92.2 is a Non-Billable / Non-Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- C92.2 Code should not be used for billing or reimbursement purposes as there are multiple ICD-10 CM codes below it that contain a greater level of detail.
- C92.2 - Atypical chronic myeloid leukemia, BCR/ABL-negative
- C92.2 - Atypical chronic myeloid leukemia, BCR/ABL-negative
- C92.20 - Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission
- C92.21 - Atypical chronic myeloid leukemia, BCR/ABL-negative, in remission
- C92.22 - Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse
Non-Billable/Non-Specific Code
The following codes above C92.2 contain annotation back-references that may be applicable to C92.2:
- Chapter: C00-D49 - Neoplasms
- Section: C81-C96 - Malignant neoplasms of lymphoid, hematopoietic and related tissue
- Category: C92 - Myeloid leukemia
Browse other similar CM codes:
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd10all.com